CHRNA7 and Parkinson disease: Dosing the α7 nAChR agonist AQW051 to Macaca fascicularis also yielded a 60% reduction in LIDs, with no further deterioration of parkinsonism [78], indicating the effectiveness of α7 nAChR agonists in nonhuman primates.